Drawing for NAUTILUS BIOTECHNOLOGY

USPTO serial 97672465

NAUTILUS BIOTECHNOLOGY

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
CASTRO, GIANCARLO
Law office
TMO LAW OFFICE 110

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NAUTILUS BIOTECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carla B. Oakley

Carla B. Oakley MORGAN, LEWIS & BOCKIUS LLP600 Montgomery Street, Suite 2300SAN FRANCISCO, CA 94111United States

Goods and services

ClassDescriptionStatusFirst use
042Scientific research; medical research; Protein screening for scientific research purposes; providing an online network service that enables users to store, analyze and share data in the field of life sciences; design and development of laboratory apparatus and instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and databases used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying and analyzing proteins and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical researchACTIVEJan 31, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 18, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 17, 2026IUAFUSE AMENDMENT FILED—
Nov 17, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 17, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 10, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 8, 2026EXT5SOU EXTENSION 5 FILED—
May 8, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 8, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 20, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 19, 2025EX4GSOU EXTENSION 4 GRANTED—
Nov 19, 2025EXT4SOU EXTENSION 4 FILED—
Nov 19, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2025EX3GSOU EXTENSION 3 GRANTED—
May 7, 2025EXT3SOU EXTENSION 3 FILED—
May 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 31, 2024EX2GSOU EXTENSION 2 GRANTED—
Oct 31, 2024EXT2SOU EXTENSION 2 FILED—
Oct 31, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 21, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 20, 2024EX1GSOU EXTENSION 1 GRANTED—
May 20, 2024EXT1SOU EXTENSION 1 FILED—
May 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 28, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 3, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 3, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 13, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 25, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 23, 2023DOCKASSIGNED TO EXAMINER—
Dec 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance